Janin Yves. 2022. “On Drug Discovery Against Infectious Diseases and Academic Medicinal Chemistry Contributions”. Beilstein Journal of Organic Chemistry 18 (January). Beilstein-Institut; {Beilstein-Institut}: 1355-78. doi:10.3762/bjoc.18.141.
Janin Yves. 2022. “Analogues of a Luciferin of Marine Origin, Few Chemistry Contributions”. In 21s International Symposium on Bioluminescence and Chemiluminescence. https://hal.science/hal-03932359.
Takatsu Kyoko, Kobayashi Naohiro, Wu Nan, Janin Yves, Yamazaki Toshio, and Kuroda Yutaka. 2023. “Biophysical Analysis of Gaussia Luciferase Bioluminescence Mechanisms Using a Non-Oxidizable Coelenterazine”. BBA Advances 3 (January). Elsevier: 100068. doi:10.1016/j.bbadva.2022.100068.
Janin Yves. 2023. “On the Origins of SARS-CoV-2 Main Protease Inhibitors”. RSC Medicinal Chemistry, October. Royal Society of Chemistry. doi:10.1039/D3MD00493G.
Gao. Tadeja, Damborsky. Jiri, Janin Yves, and Marek. Martin. 2023. “Deciphering Enzyme Mechanisms With Engineered Ancestors and Substrate Analogues”. ChemCatChem 15 (August). Wiley. doi:10.1002/cctc.202300745.
, October 2023 — Illuminating the mechanism and allosteric behavior of NanoLuc luciferase. , , working paper or preprint
Krämer Andreas, Tjaden Amelie, Ndreshkjana Benardina, Tredup Claudia, Farin Henner, Knapp Stefan, Janin Yves, and Müller Susanne. 2022. “IPP/CNRS-A017:/A/Chemical/Probe/for/Human/Dihydroorotate/Dehydrogenase/(hDHODH)”. Current Research in Chemical Biology 2 (January): 100034. doi:10.1016/j.crchbi.2022.100034.
Legrand Pierre, and Janin Yves. 2022. “On Reuben G. Jones Synthesis of 2-Hydroxypyrazines”. Beilstein Journal of Organic Chemistry. Beilstein-Institut; {Beilstein-Institut}. doi:10.3762/bjoc.18.93.